Endogena Therapeutics
Manufacturing · California, United States · 1-10 Employees
View Company Info for Free
Overview
Headquarters
111 Pine St Ste 1410, San Francisco, Cal...Phone Number
(415) 433-2262Website
www.endogena.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Mar
Apr
May
Jun
Jul
Aug
ZI Rank
1
1
1
1
1
1
About Endogena Therapeutics
Endogena Therapeutics is a clinical-stage biotech company focused on discovering and developing first-in-class endogenous regenerative medicines aimed at repairing and regenerating tissues and organs. Their innovative approach targets degenerative diseases, particularly in ophthalmology, such as retinitis pigmentosa and age-related macular degeneration, which are prevalent due to aging populations. The company collaborates with leading experts in the field to advance their clinical programs and address high unmet medical needs. By harnessing the potential of adult stem and progenitor cells, Endogena aims to revolutionize treatment paradigms for degenerative conditions.Explore more
Endogena Therapeutics Org Chart
JC
Director of Translational Medicine
Get the full picture
Sign in to uncover key details.
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Endogena Therapeutics your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Click to see if Endogena Therapeutics had a recent Job posting/layoffs
Endogena Therapeutics, which may be a good buyer, showed buying intent in Masked Content Topic
Website visits: Recent activity has been detected on your website
Funding: Get notified immidiatlly once Endogena Therapeutics has new funding data
Check out if Endogena Therapeutics is spiking on competitors!
Earning: See what the market has to say on Endogena Therapeutics recently announced quarterly report
Product Launch: Get notified when Endogena Therapeutics launches new products
Congratulate Masked Content for being promoted to Masked Content at Endogena Therapeutics
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Check if Endogena Therapeutics has recently received funding, and reach out quickly before it becomes old news!
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find 3 more new buyers
Compare Similar Companies to Endogena Therapeutics
Compare insights from companies similar to Endogena Therapeutics, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Endogena Therapeutics is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Endogena Therapeutics is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Endogena Therapeutics.
Endogena Therapeutics Tech Stack
A closer look at the technologies used by Endogena Therapeutics
See more technologies
Top Manufacturing Companies
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Endogena Therapeutics
Sign Up For FreeTo access detailed company insights
Endogena Therapeutics is a clinical-stage biotech company focused on discovering and developing first-in-class endogenous regenerative medicines aimed at repairing and regenerating tissues and organs. Their innovative approach targets degenerative diseases, particularly in ophthalmology, such as retinitis pigmentosa and age-related macular degenera... Read More
